Low Prostate Cancer-Specific Mortality Seen for Men With Localized Disease
MONDAY, March 13, 2023 (HealthDay News) — For men with localized prostate cancer, prostate cancer-specific mortality is low at 15-year follow-up, regardless of treatment assigned, according to a study published online March 11 in the New England Jour…
Learn MoreCationic Conjugated Polymer Technique Can Identify HTN Risk Alleles
MONDAY, March 13, 2023 (HealthDay News) — A cationic conjugated polymer (CCP)-based multistep fluorescence resonance energy transfer (MS-FRET) technique, which identifies hypertensive risk alleles, can improve and shorten the time to blood pressure c…
Learn MoreRemdesivir Beneficial for Subgroup Hospitalized With COVID-19
MONDAY, March 13, 2023 (HealthDay News) — For patients hospitalized with COVID-19, remdesivir is associated with reduced mortality among those receiving no or low-flow oxygen, according to a review published online Feb. 21 in The Lancet Respiratory M…
Learn MoreBenefits Persist for Lenvatinib, Pembrolizumab in Renal Cell Cancer
MONDAY, March 13, 2023 (HealthDay News) — For patients with advanced renal cell carcinoma, progression-free survival and overall survival are improved with lenvatinib plus pembrolizumab versus sunitinib, according to a study published in the March is…
Learn MorePostop Mortality Higher for Black Men Versus White Men, White Women, Black Women
MONDAY, March 13, 2023 (HealthDay News) — Black men have higher postoperative mortality than White men, White women, and Black women, according to a study published online March 1 in The BMJ.Dan P. Ly, M.D., Ph.D., from the VA Greater Los Angeles Hea…
Learn MoreShorter Primary Care Visit Length Linked to Inappropriate Prescribing
FRIDAY, March 10, 2023 (HealthDay News) — For patients with primary care visits, shorter visit length is associated with potentially inappropriate prescribing decisions, according to a study published online March 10 in JAMA Health Forum.Hannah T. Ne…
Learn MoreInsurance Status Mediates Racial, Ethnic Inequities in Cervical Cancer
FRIDAY, March 10, 2023 (HealthDay News) — Insurance status mediates racial and ethnic inequities in advanced-stage cervical cancer diagnosis, according to a study published online March 10 in JAMA Network Open.Hunter K. Holt, M.D., from the Universit…
Learn MoreNewly Approved Meds Rarely Used for Sickle Cell Disease
FRIDAY, March 10, 2023 (HealthDay News) — Newly approved medications are rarely used for sickle cell disease (SCD), according to a study published online March 8 in Blood Advances.Robert Cronin, M.D., from The Ohio State University in Columbus, and c…
Learn MoreNeoadjuvant, Adjuvant Pembrolizumab Beneficial in Resectable Melanoma
FRIDAY, March 10, 2023 (HealthDay News) — For patients with resectable stage III or IV melanoma, event-free survival is longer for those receiving neoadjuvant and adjuvant pembrolizumab compared with those receiving only adjuvant pembrolizumab, accor…
Learn MoreHydrochlorothiazide Does Not Affect Recurrence of Kidney Stones
FRIDAY, March 10, 2023 (HealthDay News) — Hydrochlorothiazide does not reduce the risk for recurrence among patients with recurrent kidney stones, according to a study published in the March 2 issue of the New England Journal of Medicine.Nasser A. Dh…
Learn More